Results 181 to 190 of about 872,427 (309)

Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough? [PDF]

Lupus Sci Med
Ruiz-Irastorza G, Paredes-Ruiz D, Arizpe F, Campos-Rodriguez V, Moreno-Torres V, Amo L, Ruiz-Arruza I, Martin-Iglesias D.   +7 more
europepmc   +1 more source

IN VITRO RESPONSE OF PERIPHERAL LYMPHOCYTES FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TO DNA

, 1968
Michihito Okubo
openalex   +2 more sources

A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus [PDF]

, 1979
John H. Klippel, Jacob Karsh, Neil Stahl, John L. Decker, Alfred D. Steinberg, Gerald Schiffman   +5 more
openalex   +1 more source

Hetrombopag: A promising thrombopoietin receptor agonist for the treatment of primary and secondary immune thrombocytopenia

Rheumatology &Autoimmunity, EarlyView.
This review seeks to provide a thorough synthesis of the existing literature on the role of thrombopoietin receptor agonists in the treatment of primary and secondary immune thrombocytopenia, with particular emphasis on the compound Hetrombopag. Abstract Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by a platelet count below
Jiaqi Hu, Zhida Fu, Xia Xu, Zhengyi Jin, Xinyu Qian, Weiyu Tao, Taiyan Ma, Dongbao Zhao, Jie Gao   +8 more
wiley   +1 more source

Haemophagocytic Lymphohistiocytosis as an Initial Presentation of Undiagnosed Systemic Lupus Erythematosus. [PDF]

Eur J Case Rep Intern Med
Alharbi LK, Ahmed AK.
europepmc   +1 more source

Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi‐omics analysis

Rheumatology &Autoimmunity, EarlyView.
Recent multi‐omics studies have demonstrated that belimumab specifically targets naïve B cells and a subset of memory B cells. This observation is consistent with belimumab's established efficacy and safety profile. Abstract Belimumab is an antibody targeting the cytokine B‐cell activating factor (BAFF), which is crucial for B cell differentiation, and
Keishi Fujio, Toshiyuki Ushijima, Tatsuki Abe, Tomohisa Okamura, Sang‐Cheol Bae, Yumi Tsuchida   +5 more
wiley   +1 more source

Role of neutrophils granularity intensity and reactive lymphocytes in assessing changes in lupus activity

Rheumatology &Autoimmunity, EarlyView.
Neut‐GI and Re‐Lymp levels correlated with changes in SLEDAl‐2K scores. Specifically, increasing in SLEDAl‐2K scores was associated with decreasing in extended inflammatory parameters. Thus, Neut‐Gland Re‐Lymp might serve as simpler and more cost‐effective alternatives to SLEDAI‐2K scores for monitoring changes in SLE activity.
Galuh Setyorini, Laniyati Hamijoyo, Evan Susandi, Delita Prihatni, Andri Iskandar Mardia, Amaylia Oehadian   +5 more
wiley   +1 more source

Bacterial infection in patients with juvenile systemic lupus erythematosus and fever. [PDF]

Pediatr Rheumatol Online J
Gómez-Urrego JF, Yepes-Madrid N, Gil-Artunduaga MA, Del Pilar Gómez-Mora M, Mejía-Rivera LF, Pacheco-López R, Rojas-Hernández JP.   +6 more
europepmc   +1 more source

Immunological studies of the placenta in systemic lupus erythematosus. [PDF]

, 1978
D M Grennan, John McCormick, Davina Wojtacha, Michael Carty, W. M. H. Behan   +4 more
openalex   +1 more source

Association of OAS1 rs1051042 polymorphism with genetic susceptibility and clinical phenotypes to systemic lupus erythematosus in a Chinese population

Rheumatology &Autoimmunity, EarlyView.
OAS1 is an interferon‐induced gene that has been reported to be associated with the susceptibility of some infectious diseases, but there is little data on OAS1 single nucleotide polymorphism (SNP) associated with Systemic lupus erythematosus (SLE).
Xin Huang, Ruifang Wu, Miao Yang, Qianwen Li, Shuaihantian Luo   +4 more
wiley   +1 more source